Virbac

Virbac Debt

The Debt of Virbac (VIRP.PA) as of Nov 2, 2026 is 288.83 M EUR. In the previous year, Debt was 307.01 M EUR — a change of -5.92% (lower).

Debt

288.83 MEUR

YoY

-5.92%

Last updated:

In 2025, Virbac's total debt was 288.83 M EUR, a -5.92% change from the 307.01 M EUR total debt recorded in the previous year.

The Virbac Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
487.24 M EUR
Jan 1, 2019
459.86 M EUR
Jan 1, 2020
115.40 M EUR
Jan 1, 2021
95.37 M EUR
Jan 1, 2022
96.86 M EUR
Jan 1, 2023
120.11 M EUR
Jan 1, 2024
307.01 M EUR
Jan 1, 2025
288.83 M EUR
The Virbac Debt history
YEARDebtYoY
288.83 MEUR-5.92%
307.01 MEUR+155.61%
120.11 MEUR+24.00%
96.86 MEUR+1.56%
95.37 MEUR-17.35%
115.40 MEUR-74.91%
459.86 MEUR-5.62%
487.24 MEUR-3.81%
506.55 MEUR-14.93%
595.48 MEUR-8.94%
653.95 MEUR+14.68%
570.25 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Virbac Stock analysis

What does Virbac do? Virbac SA is a French company specializing in animal medicines and care products. The company was founded in 1968 by Pierre Richard Dick, who studied veterinary medicine at the École nationale vétérinaire d'Alfort and gained experience as a veterinarian. Since its founding, Virbac SA has been headquartered near Carros, France and operates worldwide. The business model of Virbac SA is to offer a wide range of products to veterinarians and pet owners, aiming to ensure optimal health, care, and quality of life for their pets. This includes everything from vaccines, diagnostics, and medications to grooming products that veterinarians and pet owners need to ensure optimal pet healthcare. Virbac SA has five main business areas, namely livestock, pets, horses, hygiene products, and specialties. The livestock sector includes products such as feed additives and antiparasitics tailored to the specific needs of cattle, pigs, poultry, and fish. In the pets sector, Virbac SA offers products specifically tailored to dogs, cats, birds, and other pets. This includes both disease prevention and treatment products. In the horse sector, the company offers products for the maintenance, care, and health of horses. Another division of Virbac SA is hygiene products. The company offers a wide portfolio of products and solutions that support both veterinarians and pet owners in ensuring the health and care of animals. This ranges from infection control products to animal-specific shampoos and grooming items. The specialties sector, on the other hand, includes specialized products such as targeted diagnostics, therapeutics, and dietary supplements. The constant focus on research and development also leads to innovative product launches that consistently meet the highest quality standards. An example of this is the scientifically developed dental hygiene product line that improves both the oral health and breath quality of dogs and cats. For this, Virbac SA also receives awards from the Veterinary Center for Clinical Medicine in Munich. Through a systematic international expansion strategy, Virbac SA is now present in more than 100 countries. The company employs over 4,800 people worldwide and achieved a turnover of 954 million euros in 2019. Overall, Virbac SA stands for consistently high product quality and a strong customer orientation. With a combination of expertise and extensive scientific research and development, particularly in the field of animal health and care, the company is an important player in the global animal medicine manufacturing market. Virbac is one of the most popular companies on Eulerpool.

Debt Details

Understanding Virbac's Debt Structure

Virbac's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Virbac's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Virbac’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Virbac’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Virbac stock

Debt of Virbac is 288.83 M EUR in 2025.

Debt of Virbac changed from 307.01 M EUR to 288.83 M EUR, representing a -5.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Virbac since 2006 – with annual values, charts, and detailed analysis.

Debt's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Virbac historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Virbac

All Key Metrics — Virbac